Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 33Not yet recruiting 26Completed 20Unknown 11Active not recruiting 5Withdrawn 3Terminated 3Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Somatostatinoma 1Small Cell Lung Carcinoma 1Glioblastoma 1

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × irinotecan sucrosofate × Clear all
NCT03736720 2025-01-30

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Roswell Park Cancer Institute

Phase 2 Terminated
11 enrolled 17 charts

Somatostatinoma

NCT05049863 2024-12-05

Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)

Washington University School of Medicine

Phase 1 Terminated
17 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03119064 2022-12-13

329

Brown University

Phase 1/2 Terminated
12 enrolled 13 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡